Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Toronto
SEC filing record 1 source field available
Fiscal year end
31 December
Aptose Biosciences Inc. has filed 1,073 SEC EDGAR filings since 14 Feb 1997

SEC filing history

Showing 126-150 of 865 matching filings.

Per page
25
Current page
6
UPLOAD File 333-281201

UPLOAD filing

Filing date
02 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-281201

S-1

Filing date
02 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-32001

DEF 14A

Filing date
17 Jul 2024
Reporting date
15 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-32001

PRE 14A

Filing date
05 Jul 2024
Reporting date
15 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-267801

424B5

Filing date
03 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-32001

DEF 14A

Filing date
15 May 2024
Reporting date
18 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 May 2024
Reporting date
23 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-32001

PRE 14A

Filing date
30 Apr 2024
Reporting date
18 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .